![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Journal of Virology, July 2006, p. 6771-6783, Vol. 80, No. 14
0022-538X/06/$08.00+0 doi:10.1128/JVI.00492-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
,
Chad D. Williamson,1,2,
Victor S. Goldmacher,3 and
Anamaris M. Colberg-Poley1,2,4*
Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue NW, Washington, D.C. 20010,1 Department of Biochemistry and Molecular Biology, George Washington University, Washington, D.C. 20037,2 ImmunoGen, Inc., 128 Sidney Street, Cambridge, Massachusetts 02139,3 Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, D.C. 200374
Received 9 March 2006/ Accepted 28 April 2006
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-helix contributes to either correct folding or stability of gpUL37. Insertion of the UL37x3 hydrophobic core and cleavage site into pUL37M, a splice variant of gpUL37 which lacks these sequences and is neither proteolytically cleaved nor N glycosylated, resulted in its internal cleavage and N glycosylation. Its NH2-terminal fragment, pUL37M-NH2, was detected more abundantly in mitochondria, while its N-glycosylated C-terminal fragment, gpUL37M-COOH, was detected predominantly in the ER in a manner analogous to that of gpUL37 cleavage products. These results indicate that UL37x3 aa 178 to 205 are prerequisite for gpUL37 internal cleavage and alter UL37 protein topology allowing N glycosylation of its C-terminal sequences. In contrast, the NH2-terminal UL37x1 hydrophobic leader, present in pUL37x1, pUL37M, and gpUL37, is not cleaved from mature UL37 protein, retaining a membrane anchor for UL37 isoforms during trafficking. Taken together, these results suggest that HCMV gpUL37 undergoes sequential trafficking, during which it is ER translocated, processed, and then mitochondrially imported. |
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
HCMV gene expression is temporally regulated, and products from the UL37 immediate-early locus are important for viral growth in cultured fibroblasts and in vivo (19, 24, 34, 39, 54). Alternative processing of HCMV UL37 immediate-early pre-mRNA produces a predominant unspliced UL37 exon 1 (UL37x1) RNA and at least 10 alternatively spliced UL37 RNAs (1-3, 23, 26, 48-50). These transcripts encode multiple UL37 protein isoforms (Fig. 1A).
|
All three known UL37 proteins, pUL37x1, the full-length glycoprotein (gpUL37), and the medium protein (pUL37M), contain the NH2-terminal UL37x1 sequences (11, 23, 26) (Fig. 1A). These sequences include a hydrophobic signal peptide (amino acids [aa] 1 to 22) and juxtaposed basic residues, which serve as a bipartite signal to target UL37 proteins to the ER and mitochondria (29). As it is not currently known whether this signal peptide is cleaved, we examined its retention on mature pUL37x1.
Two short domains (aa 5 to 34 and aa 118 to 147) within UL37x1 are, together, sufficient to confer antiapoptotic activity, and they act by targeting the protein to mitochondria and binding Bax, respectively (5, 23, 24, 31-33, 38). A strongly acidic domain within UL37x1 plays a role in the transactivation of HCMV early gene promoters (14, 55). The full-length gpUL37 further shares exon 2 and part of exon 3 (UL37x3), including 11 of its 17 N-glycosylation sites as well as a C-terminal transmembrane (TM) domain and cytosolic tail with pUL37M (4, 11, 23, 25, 26).
Within the gpUL37 unique sequences are a consensus ER signal peptidase I cleavage site at aa 193/194 and a hydrophobic core spanning aa 178 to 196, which are predicted to fold into an -helical structure compatible with a membrane-spanning sequence (11, 26, 30). Our previous studies show internal cleavage of gpUL37 in transfected cells (30). Cleavage of proteins by type I signal peptidases occurs at NH2-terminal as well as internal signal sequences on the luminal side of the ER membrane, with the enzymes favoring small, uncharged residues at positions –1 and –3 with respect to the cleavage site (28). The potential UL37x3 cleavage site (aa193/194) is located on the periphery of the hydrophobic helix, is predicted to abut or extend into the ER lumen, and contains glycine residues at the –1 and –3 positions.
The gpUL37 cleavage products, pUL37NH2 and gpUL37COOH, dissociate and traffic differentially. The NH2-terminal cleavage product (pUL37NH2) is detected in the ER and mitochondria (30). However, it was not clear whether the mitochondrial pUL37NH2 species traffics to the ER prior to its relocation to mitochondria. The C-terminal cleavage product (gpUL37COOH) is N glycosylated and preferentially retained in the secretory pathway. This divergent cleavage product trafficking is in contrast to other internally cleaved HCMV glycoproteins, such as glycoprotein B (gB), whose proteolytic fragments remain joined by disulfide bonds and traffic jointly through the secretory apparatus (9, 16, 44, 46). Cleavage of the UL37 precursor does not require N glycosylation (30). pUL37M lacks UL37x3 aa 178 to 262 and, accordingly, is not internally cleaved. Unexpectedly, pUL37M is not N glycosylated, even though it has 11 consensus N-glycosylation signals (30).
In these studies, we generated gpUL37 mutants to test the requirements for UL37 precursor internal cleavage. We found that internal cleavage occurred at the consensus ER signal peptidase I site and that its mutation resulted in decreased cleavage. The full-length gpUL37 cleavage site mutant was modified by N glycosylation prior to its importation into the mitochondrial outer membrane. On the converse side, insertion of the consensus UL37x3 ER signal peptidase I site and overlapping hydrophobic sequences enabled cleavage of the UL37M isoform. In contrast to the internal UL37x3 site, the UL37x1 hydrophobic leader peptide was not cleaved from the mature protein, allowing for membrane anchoring of UL37 proteins during their subcellular trafficking.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
aa180-184-Flag, p1332), gpUL37 cleavage site mutant I (gpUL37 G191Y,G193Y-Flag, p1333), gpUL37 hydrophobic core mutant II (gpUL37 S189R,G193Y-Flag, p1337), the pUL37M insertion mutant (pUL37M::aa178-205-Flag, p1365), or empty vector DNA (p790, p792) by using Lipofectamine 2000 (Invitrogen) at a ratio of 1.75:1 (lipid:DNA) in OptiMEM. HeLa cells were harvested at 24 h after transfection and fractionated as described below. HFFs were harvested at 24 h after transfection and analyzed by indirect immunofluorescence as detailed below. Mutant generation. Mutant expression vectors encoding gpUL37 hydrophobic core mutant I (p1332), gpUL37 cleavage site mutant I (p1333), and gpUL37 hydrophobic core mutant II (p1337) were generated by site-directed mutagenesis of the UL37 open reading frame (ORF) in p816 (15) using the QuikChange kit (Stratagene) following the manufacturer's instructions. The pUL37M insertion mutant (p1365) was generated by deletion of aa 206 to 262 from the gpUL37 ORF in p816. The mutations were verified by DNA sequencing of the mutant plasmids.
Isolation of mitochondria. Mitochondria were purified on discontinuous sucrose gradients as previously described (15, 29). Briefly, cells in MTE buffer (0.27 M mannitol, 10 mM Tris-HCl, 0.1 mM EDTA, pH 7.4) supplemented with protease inhibitor cocktail (Sigma) were lysed by sonication. Nuclei and cellular debris were removed by centrifugation at 700 x g for 10 min. Mitochondria were obtained by pelleting at 15,000 x g for 10 min, and the postmitochondrial supernatant was used for purification of ER fractions. Crude mitochondria were purified by banding in discontinuous sucrose gradients and by dilution in MTE buffer and pelleting at 15,000 x g for 10 min. Finally, purified mitochondria were resuspended in phosphate-buffered saline (PBS) and stored at –80°C until use.
ER fraction isolation. ER fractions were isolated as previously described (29, 36). Briefly, the postmitochondrial fraction described above was layered on a sucrose step gradient consisting of 1.3 M, 1.5 M, and 2.0 M sucrose in 10 mM Tris-HCl (pH 7.6) and banded by centrifugation at 100,000 x g for 70 min. The ER fraction at the interface between the supernatant and the 1.3 M sucrose step was collected, diluted with MTE buffer, and pelleted by centrifugation at 100,000 x g for 45 min. The ER membranes were resuspended in PBS and stored at –80°C until use.
Protein concentration determination. Protein concentrations of the subcellular fractions were determined using a BCA reagent kit (Pierce) as suggested by the manufacturer.
Deglycosylation using PNGase or EndoH. Endoglycosidase reactions were performed as recommended by the manufacturer (New England BioLabs), as previously described (30). Following denaturation, 10 to 20 µg of ER or mitochondrial protein was digested with 500 U of the desired enzyme (peptide:N-glycosidase F [PNGase] or endoglycosidase H [EndoH]) in the presence of the appropriate buffer for 30 min at 37°C. Deglycosylated proteins were precipitated using 80% cold acetone and resuspended in 1x sodium dodecyl sulfate (SDS) loading buffer for subsequent separation on SDS-10% polyacrylamide gel.
Indirect immunofluorescence staining. HFFs (1 x 105) were plated onto Lab-Tek II four-chambered cover glass borosilicate slides (Lab-Tek). Twenty-four hours later, cells were lipofected with vectors expressing gpUL37 cleavage site mutant I-Flag (p1333) or gpUL37-Flag (p816). Twenty-four hours after lipofection, cells were fixed with 4% paraformaldehyde in 1x PBS for 30 min. Fixed cells were washed with 1x PBS, permeabilized with 1x PBS plus 0.75% Triton X-100, blocked for 45 min using 1x PBS plus 4% bovine serum albumin (BSA), and sequentially probed with primary antibodies (Ab) at a dilution of 1:250 for 1 to 2 h in 1x PBS plus 4% BSA at room temperature. UL37 NH2-terminal and C-terminal sequences were detected by immunofluorescence staining with Ab1064 or anti-Flag (rabbit anti-Flag M2 antibody; Sigma). The ER and mitochondria were visualized using mouse anti-protein disulfide isomerase (PDI, 1:250; StressGen) and human autoimmune serum against mitochondria (1:250; ImmunoVision) as published (15). The corresponding secondary antibodies were used at 1:250 dilutions in 1x PBS plus 4% BSA. Secondary antibodies used were fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (IgG; Jackson ImmunoResearch), Texas Red (TR) goat anti-mouse IgG (Kirkegaard and Perry Laboratories), and cyanine 5 (Cy5)-conjugated goat anti-human IgG (Jackson ImmunoResearch).
Confocal laser scanning microscopy. Analyses on transfected cells were performed with a Bio-Rad MRC1024 confocal laser scanning microscope (Center for Microscopy and Image Analysis, GWU, and Children's Mental Retardation and Developmental Disabilities Research Center) which allows for triple excitation. Triple excitation lines at 488, 568, and 647 nm were used for the excitation of FITC, TR, and Cy5, respectively. Emission was measured at 520 (FITC), 615 (TR), and 670 (Cy5) nm. Individual signals were captured sequentially to avoid spurious overlap of the emission signals. Individual optical sections, obtained using z dimensions of between 0.5 and 1 µm, were examined to determine colocalization of UL37 proteins with cellular organelle markers. Optical sections were obtained using a 100x (numerical aperture, 1.35) lens. Images were generated using Adobe Photoshop (version 7.0.1), Bio-Rad plug-ins, and Microsoft PowerPoint 2003.
Western analyses. Fractionated proteins (10 to 20 µg) were separated by electrophoresis in SDS-10% polyacrylamide gels and transferred onto polyvinylidene difluoride (PVDF; Bio-Rad) or nitrocellulose (Hybond-ECL; Amersham Biosciences) membranes using a wet-transfer apparatus at 50 V for 1 h (47). Western analyses were carried out by a chemiluminescent method using the ECL Western blotting detection system (Amersham Pharmacia Biotech). Blots were blocked with 5% milk protein (Bio-Rad) in PBS with 0.005 to 0.1% Tween 20 for 30 min at room temperature or overnight at 4°C. Blotted proteins were reacted with primary Ab, including rabbit anti-UL37x1 aa 27 to 40 (Ab1064 at 1:1,000 or DC35 at 1:6,000), mouse anti-Flag (M2 at 1:2,000; Covance), goat anti-dolichyl phosphate mannose synthase 1 (DPM1) (I-20 at 1:500; Santa Cruz Biotechnology), or mouse anti-glucose regulated protein 75 (GRP75) (SPA-825 at 1:1,000; StressGen Biotechnologies) for 1 h in PBS with 0.005 to 0.1% Tween and 5% milk protein or 1% BSA (Bio-Rad) and with the corresponding horseradish peroxidase-conjugated secondary antibody (1:2500; Bio-Rad). When reprobed, blots were stripped by washing the membranes in the presence of 25 mM Tris-HCl (pH 6.4), 1% SDS, and 10 mM ß-mercaptoethanol at 50°C for 20 to 40 min. The stripping buffer was removed by washing two to five times in PBS with or without 0.1% Tween 20 (5 to 10 min) and two to five times with PBS, 0.1% Tween 20, and 5% dried milk (15 min). The blots were then reprobed with the appropriate antibodies. Each blot is representative of a minimum of three independent experiments. Digital images were generated using ScanWizard Pro version 1.21 and imported into Adobe Photoshop version 5.0 LE and Microsoft PowerPoint 2000.
Microsequencing of the pUL37x1 NH2-terminal sequences. HeLa cells stably expressing pUL37x1 tagged with triple myc peptide at its C terminus (HeLa/UL37x1#3) (23) were lysed in 150 mM NaCl-5 mM EDTA-50 mM Tris-HCl (pH 8.0)-1% Triton X-100 in the presence of protease inhibitors and centrifuged at 10,000 x g at 4°C for 10 min. The supernatants were precleared with ethanolamine-treated Affi-Prep 10 beads (Bio-Rad), then incubated with 9E10 anti-myc antibody (20) covalently linked to Affi-Prep 10 beads and washed with the lysis buffer. Proteins were eluted from beads in nonreducing Laemmli sample buffer and then separated by using SDS-polyacrylamide gel under reducing conditions and transferred onto PVDF membrane. The band containing pUL37x1-myc was stained with amido black and isolated. Sequence analysis of the protein was performed at the Laboratory for Protein Microsequencing and Mass Spectroscopy, University of Massachusetts Medical School (John Leszyk).
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-helical folding in this region. Intriguingly, we also found a consensus site for ER signal peptidase I at aa 191 to 194 within this region, predicting proteolytic cleavage between aa 193 and 194 (30). Another UL37 isoform, pUL37M, contains the NH2-terminal signal sequence and the C-terminal TM anchor but not the internal hydrophobic core at aa 178 to 196. Finally, the predominant UL37 protein, pUL37x1, carries only the NH2-terminal hydrophobic signal sequence.
In order to verify the UL37 internal cleavage site and the requirements for its proteolytic cleavage, we generated UL37 mutants, which disrupt the consensus ER signal peptidase I site or its partially overlapping hydrophobic core (Fig. 1A). Mutations were introduced to specifically disrupt ER signal peptidase I recognition of the potential cleavage site (gpUL37 cleavage site mutant I) by replacing the small, uncharged glycine residues at positions –1 and –3 with bulky tyrosine residues. This mutation did not disrupt the predicted hydrophobic -helix spanning aa 178 to 196. The second mutant (gpUL37 hydrophobic core mutant I), lacking aa 180 to 184, exclusively disrupted the proposed internal TM domain by shifting it to span UL37x2 encoded residues (starting at aa 164). The third UL37 mutant (gpUL37 hydrophobic core mutant II) introduced a charged residue (R) within the internal hydrophobic core and a single tyrosine residue at the –1 cleavage position. Insertion of the R into the hydrophobic core was disruptive to the -helix and also shifted the predicted -helix to upstream sequences within the UL37x2 coded domain (starting at aa 170).
Verification of the UL37x3 site of internal cleavage.
Introduction of a bulky residue (Y) at the critical –1 and –3 positions, of the predicted UL37x3 internal ER signal peptidase I site (aa 193/194) prevented internal cleavage of the mutant gpUL37 (Fig. 2). The gpUL37 cleavage site mutant I was detected by Ab1064, against UL37x1 amino-terminal sequences, as a full-length, uncleaved species of 
105 kDa in both purified ER and mitochondrial subcellular fractions. The NH2-terminal UL37 cleavage fragment, pUL37NH2, was primarily detected in mitochondrial fractions from control cells expressing the parental gpUL37. Inhibition of gpUL37 internal cleavage by the aa 191 and 193 mutations confirms our earlier prediction of gpUL37 internal cleavage between residues 193 and 194 (30).
|
105 kDa) was also detected using anti-Flag antibody in purified ER and mitochondrial fractions. In this experiment, some cleavage of gpUL37 cleavage site mutant I was detected by the presence of the gpUL37COOH fragment, comigrating with the product of the wild-type gpUL37COOH, suggesting that this mutant is inefficiently internally cleaved compared to wild-type gpUL37.
|
|
105 kDa) exceeded its ORF and retains its 17 consensus N-glycosylation signals, we examined its N glycosylation (Fig. 5). Purified mitochondrial fractions from cells expressing gpUL37 cleavage site mutant I or control wild-type gpUL37 were treated with PNGase. Treatment with PNGase increased the electrophoretic mobility of gpUL37 cleavage site mutant I from 105 kDa to 60 kDa in mitochondrial (Fig. 5A) and ER fractions (Fig. 5B). The mobility of control pUL37NH2 fragment detected in mitochondria and ER fractions by Ab1064 was not altered by PNGase treatment (Fig. 5A and B), consistent with its lack of N-glycosylation sites. These results strongly suggest that full-length gpUL37 cleavage site mutant I is processed in the ER lumen by N glycosylation prior to its trafficking to mitochondria. Further, this finding also establishes that gpUL37 internal cleavage is not required for its N glycosylation. This result is complementary to our previous finding that N glycosylation of pUL37COOH is not required for UL37 precursor cleavage (30), suggesting that initiation of these events can be separated.
|
105 kDa) was sensitive to EndoH treatment, indicating that its oligosaccharides were not further processed. These results are consistent with modification of the UL37 glycoprotein in the ER lumen, but not in the medial or trans-Golgi apparatus, prior to its mitochondrial importation. As anticipated, mitochondrial GRP75 was detected in the banded mitochondrial fractions (Fig. 5C), whereas the ER marker, DPM1, was not (C. D. Williamson and A. M. Colberg-Poley, unpublished results).
gpUL37 hydrophobic core mutant I.
Hydrophobic domains are known to influence the timing and efficiency of protein cleavage and N glycosylation (41). The UL37x3 hydrophobic core is highly conserved in primate CMVs (18, 32). To determine the role of the hydrophobic core in pUL37 proteolytic cleavage and N glycosylation, we generated a gpUL37 mutant which lacks a portion of the UL37x3 internal hydrophobic core (aa180-184). However, upon repeated attempts, this gpUL37 mutant was not detectable either as uncleaved protein or as cleaved fragments in purified ER and mitochondrial fractions from transfected HeLa cells (Fig. 2) (Williamson and Colberg-Poley, unpublished). Thus, partial deletion of the internal hydrophobic core sequences appears to either lead to incorrect protein folding or decrease gpUL37 protein stability.
gpUL37 hydrophobic core mutant II.
In an alternative approach to examine the role of the UL37x3 internal hydrophobic core on UL37 protein cleavage and N glycosylation, we generated a single amino acid substitution (S189R) which predictably disrupts the hydrophobic core. This mutant also carries the –1 residue bulky-group substitution (G193Y) in the stable pUL37 cleavage site mutant described above. Surprisingly, gpUL37 hydrophobic core mutant II (105 kDa) was dramatically decreased in purified ER fractions and undetectable in mitochondrial fractions from transfected cells even though the parental wild-type pUL37NH2 was readily detected in mitochondria (Fig. 6A). These results are consistent with the decreased stability of gpUL37 hydrophobic core mutant I and underscore the likely importance of these UL37x3 sequences for gpUL37 stability or folding.
|
105 kDa to 60 kDa by PNGase treatment, consistent with its modification by N glycosylation. Internal proteolytic cleavage and N glycosylation of a pUL37M insertion mutant. pUL37M, which lacks aa 178 to 262 and consequently both the internal hydrophobic core and ER signal peptidase I site, traffics both into the ER and into mitochondria but is neither internally proteolytically cleaved nor N glycosylated (30). To determine whether the UL37x3 domain is sufficient to enable UL37 cleavage, we inserted aa 178 to 205 into pUL37M insertion mutant I. pUL37M insertion mutant I was stably expressed and readily detected in transfected cells (Fig. 7). Moreover, it was cleaved internally and its NH2-terminal fragment, pUL37M-NH2, was readily detected in mitochondria by Ab1064 (Fig. 7A). pUL37M insertion mutant I behaved analogously to wild-type gpUL37 in producing proteolytic fragments not normally observed in pUL37M. The pUL37M-NH2 fragment comigrated with pUL37NH2 from gpUL37, consistent with cleavage at the authentic UL37x3 internal site. These results independently verify use of internal signal peptidase site I at aa 193/194.
|
60 kDa) was greater than that of its 28-kDa predicted ORF, suggesting its modification by N glycosylation. In addition to gpUL37M-COOH, the C-terminal fragment from wild-type gpUL37, gpUL37COOH, was detected by its C-terminal Flag tag. As previously observed, the gpUL37COOH was detected predominantly in the purified ER fractions, and its apparent molecular mass was 80 kDa. Finally, full-length pUL37M insertion mutant I was detected, and its molecular mass corresponded well with its predicted mass of 51 kDa. The parental pUL37M, which is not Flag tagged, was not detected by anti-Flag antibody but was detected by Ab1064.
To determine whether pUL37M insertion mutant I was N glycosylated, we treated ER fractions expressing this mutant with either PNGase or EndoH (Fig. 7C). The apparent molecular mass of the C-terminal fragment of pUL37M insertion mutant I (gpUL37M-COOH) was decreased from 50 kDa by PNGase (31 kDa) and by EndoH (32 kDa) treatment, similar to gpUL37COOH. Again, the parental pUL37M, which is not Flag tagged, was not detected by anti-Flag antibody. Taken together, these results suggest that gpUL37M-COOH is produced by cleavage at the authentic UL37x3 cleavage site and is N glycosylated, mimicking wild-type gpUL37 C-terminal fragment behavior. Furthermore, these results argue that UL37x3 residues 178 to 205 are prerequisite for UL37 protein cleavage, direct downstream UL37 sequences into the ER lumen, and enable N glycosylation of the UL37 precursor.
The NH2-terminal hydrophobic signal sequence of pUL37x1 is not cleaved. The NH2 terminus of pUL37x1 has a 22-amino-acid-long hydrophobic segment resembling a leader sequence (26). This sequence is invariant in 26 HCMV primary strains (24) and is highly conserved among primate CMVs (18, 32). This amino acid segment is required for translocation of UL37-encoded proteins into the secretory apparatus and into mitochondria (24, 26, 29). To determine whether the pUL37x1 leader peptide is cleaved or not during protein maturation, we examined the NH2-terminal sequence of pUL37x1 by protein microsequencing analysis. For these experiments, we used HeLa/UL37x1 cells constitutively expressing pUL37x1 tagged with a triple myc peptide at its C terminus. Previously, we have shown that the tagged protein traffics to mitochondria both in stably transfected and in HCMV-infected human cells (5, 23). Lysates from HeLa cells stably transfected with pUL37x1-myc were incubated with anti-myc antibody covalently immobilized on beads, and captured proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE). The pUL37x1-myc band, identified by Western blotting with anti-myc antibody in a procedure similar to that previously described (23), was then analyzed by protein microsequencing without prior partial tryptic digestion. This experiment revealed that the band consisted of three pUL37x1 proteins with various NH2-terminal sequences starting at aa 5 (sequence, YVNLLGSVGLLA; 21 pmol), aa 1 (MSPVYVNLLGSV; 12 pmol), or aa 2 (SPVYVNLLGSVG; 7 pmol) of their corresponding NH2 termini (Table 1). Such ragged NH2 termini are commonly observed during microsequencing of cellular proteins and possibly produced by cellular exopeptidases, either as a part of normal intracellular processing or after the release of these enzymes during cell lysis (John Leszyk, personal communication). This result indicates that the first 22 NH2-terminal residues of pUL37x1 (and, by extension, of gpUL37 and pUL37M), are not cleaved. Thus, this hydrophobic core is a noncleavable leader peptide, in agreement with the finding that it is required for mitochondrial targeting and the antiapoptotic activity of pUL37x1 (23, 24, 29), and with the lack of any known proteolytic cleavage signal. Taken together, these results imply that pUL37x1, gpUL37, and pUL37M NH2 termini remain anchored in the membrane by virtue of their uncleaved NH2-terminal sequences while trafficking through the secretory apparatus and to mitochondria.
|
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Based upon the presence of the UL37x3 consensus ER signal peptidase I site and the sizes of gpUL37 cleavage products, we had predicted that the UL37 precursor would be cleaved between aa 193 and 194 (30). To determine whether this is indeed the case, we inserted bulky tyrosine residues in positions (–1, –3) that were critical with respect to the predicted UL37x3 internal cleavage site. The extent of cleavage of the gpUL37 cleavage site mutant I at the internal site was greatly reduced. Nonetheless, the full-length cleavage site mutant I protein was stable and readily detected in transfected cells. As predicted by HMMTOP, these mutations do not change the overlapping UL37x3 hydrophobic core -helix (aa 178 to 196). Because mutation of the critical –1 and –3 residues severely compromised gpUL37 cleavage, we concluded that the UL37x3 consensus signal peptidase I site is recognized upon translocation into the ER membrane and that HCMV pUL37 is internally cleaved at aa193/194. Moreover, the identity of the UL37x3 internal cleavage site was independently verified by insertion of UL37x3 aa 178 to 205 into another HCMV UL37 isoform, pUL37M, which normally lacks these sequences and is neither internally cleaved nor N glycosylated (30). Insertion of these UL37 sequences resulted in cleavage of pUL37M insertion mutant I mutant and N glycosylation of its C-terminal fragment.
Hydrophobic domains are known to influence the timing and efficiency of protein cleavage and N glycosylation (41). The UL37x3 ER signal peptidase I site lies within an internal hydrophobic core (aa 178 to 196) (30). This region is highly conserved between primate (chimpanzee and rhesus) CMV and HCMV (18, 32), suggesting its functional importance. In contrast to gpUL37 cleavage site mutant I, the deletion of aa 180 to 184 within the UL37x3 internal hydrophobic core, spanning a leucine-rich motif, reduced the abundance of the gpUL37 hydrophobic core mutant I protein to an undetectable level, suggesting that the alteration of the UL37x3 hydrophobic core resulted in either incorrect folding or instability of the protein. HMMTOP analysis predicted that deletion of aa 180 to 184 would disrupt the UL37x3 hydrophobic core by shifting it some 14 residues within UL37x2 sequences towards the NH2 terminus of gpUL37, which might contribute to the instability of the mutant protein.
To independently examine the importance of the internal UL37x3 hydrophobic core (aa 178 to 196) for gpUL37 processing, we disrupted the core by substitution of a single residue in the helix with a charged residue (R), together with a second point mutation at position –1 (G193Y) of the internal cleavage site. This latter mutation is also present in the stable gpUL37 cleavage site mutant I described above. The level of expression of this UL37 hydrophobic core mutant II was also markedly reduced, suggesting its instability. HMMTOP predicted that S-to-R mutation would shift the -helix within the UL37x3 hydrophobic core 8 amino acids towards the NH2 terminus, similarly to the UL37 hydrophobic core mutant I. These data suggest that changes in the UL37x3 hydrophobic -helix contribute to the instability of gpUL37. Previous reports show that introduction of a negatively charged residue into the gamma-aminobutyric acid receptor TM domain resulted in its ER-associated degradation (21) and that an L-to-P substitution in cystic fibrosis TM conductance regulator protein also produced an unstable mutant protein (13). Taken together, our results suggest that the UL37x3 internal hydrophobic core -helix plays an important role in gpUL37 protein cleavage and stability.
The known UL37 isoforms, pUL37x1, gpUL37, and pUL37M, share UL37x1 and some UL37x3 sequences but differ in the presence of the UL37x3 hydrophobic core. HMMTOP analysis predicts that because of these changes, pUL37x1, gpUL37, and pUL37M should have distinct topologies (Fig. 8). pUL37x1 contains only the UL37x1 hydrophobic signal peptide. Based upon the pUL37x1 microsequencing results, we conclude that its NH2-terminal signal sequence is noncleaved. This conclusion is in agreement with the presence of large bulky groups close to the cleavage site, which predicts it to be a poor substrate for ER signal peptidase I (28), and with the cell death suppressor activity of pUL37x1, which requires the presence of the leader peptide (23, 24). Although the signal peptide is not cleaved it still is sufficient to drive ER translocation of pUL37 proteins (29). In this property, pUL37 proteins are similar to another HCMV membrane protein, US2, whose signal peptide is noncleavable and yet drives US2 ER translocation (22). Furthermore, the UL37 NH2-terminal signal peptide in combination with adjacent basic residues serves as a bipartite signal for mitochondrial targeting of UL37 proteins (29).
|
The HMMTOP analysis predicts the UL37x3 hydrophobic core to direct the downstream UL37x3 sequences into the ER lumen, permitting processing of the consensus N-glycosylation signals. This prediction is supported by the finding that introduction of the UL37x3 internal hydrophobic core into UL37M resulted in its internal cleavage and N glycosylation of its 11 consensus sites, shared with gpUL37. Furthermore, these results suggest that the absence of N glycosylation of pUL37M consensus sites (30) is due to its topology; that is, absence of the UL37x3 internal hydrophobic core results in their retention on the cytosolic side of the ERN membrane, making its sites inaccessible to the ER N glycosylation machinery.
As pUL37M lacks the internal hydrophobic core (aa 178 to 196), its NH2-terminal sequences remain localized on the cytosolic side of the ER membrane up to the UL37x3 TM (aa 433 to 459), which serve as a second membrane anchor. This predicted pUL37M topology is supported by the unanticipated finding of the lack of modification at its 11 consensus N-glycosylation sites. Following insertion of the UL37x3 internal hydrophobic core, pUL37M was internally cleaved and its consensus N-glycosylation sites were modified, indicating that the downstream UL37 sequences, including its N-glycosylation signals, are driven into the ER lumen.
N glycosylation of full-length gpUL37 occurs in the absence of cleavage of NH2-terminal signal peptide. In this property gpUL37 is similar to prolactin, in which in vitro transport studies indicated that signal sequence cleavage is not prerequisite for the N glycosylation (41), and influenza virus neuraminidase, which actually requires an uncleaved signal sequence at the NH2 terminal for its N glycosylation (27). In contrast, signal peptidase cleavage was found to be essential for N glycosylation in the yeast system (12). We had previously found that N glycosylation is not required for internal cleavage of gpUL37 (30). Thus, UL37 internal cleavage and N glycosylation can be dissociated. However, signal sites are reported to be more readily cleaved when the hydrophobic domain is short, so that it maintains proper positioning through the ER translocon (28). Similar to N glycosylation, precursor cleavage predominantly occurs cotranslationally but can be inefficient or delayed depending on the primary sequence of the protein. Predictably, the timing of signal cleavage could affect the retention of protein fragments within the ER. Nonetheless, we had found an unanticipated relationship between stability of the UL37 NH2-terminal fragment and N glycosylation of its C-terminal fragment, gpUL37COOH. In the presence of tunicamycin, an inhibitor of N glycosylation, UL37NH2 was decreased in stability (30). Although the UL37 cleavage and N-glycosylation events can be dissociated, we cannot yet conclude that they are completely independent.
Protein secondary-structure analysis predicts that the C-terminal TM would direct downstream gpUL37 sequences to traverse the ER membrane, orienting its short tail (aa 460 to 487) into the cytosol. This prediction is consistent with the N glycosylation of gpUL37 consensus signals and the finding that the short gpUL37 tail is sensitive to protease digestion (4).
The full-length UL37 mutant glycoproteins localized to both the ER and mitochondria. Since transfer of oligosaccharides to the peptide backbone at consensus N-glycosylation signals occurs in the ER and the mitochondrial UL37 N-glycosylated species are EndoH sensitive, we conclude that the UL37 mutant glycoproteins have been processed posttranslationally in the ER/cis-Golgi apparatus prior to their relocation to mitochondria. These findings are consistent with our previous observations that wild-type gpUL37 is ER translocated and internally cleaved by ER signal peptidase I and that its NH2-terminal product is mitochondrially imported. In contrast to the wild-type gpUL37, the full-length N-glycosylated mutant protein is mitochondrially imported. By extension, our evidence suggests that upon ER cleavage of wild-type gpUL37, its NH2-terminal fragment is also subsequently imported into the mitochondria. Moreover, the dual trafficking of pUL37x1 and pUL37M to the ER and mitochondria would be predicted to occur in the same sequential order. Other mitochondrially associated proteins have been found to traffic sequentially from the ER to mitochondria. Spiro and colleagues identified an N-glycosylated cellular protein which traffics from the ER to the internal mitochondrial membrane (10). More recently, the hepatitis C core protein was found also to target the ER and then traffic to mitochondria (42).
This ER-mitochondrial sequential trafficking model is consistent with the finding that deletion of the hydrophobic residues of the UL37 bipartite leader sequence (aa 2 to 23) blocked both ER and mitochondrial trafficking, while deletion of the juxtaposed basic residues (aa 23 to 34) blocked mitochondrial importation but permitted ER translocation (29).
There are several potential pathways for UL37 protein targeting to mitochondria following ER translocation and modification. In one model, the translocon channel may be transiently opened during the process of translocation and N glycosylation. This could allow the NH2 terminal fragment to be retrotranslocated from the ER into the cytosol, as in the ER-associated degradation pathway (53). A translocon channel component, sec61B, is known to be involved in retrotranslocation of proteins to be targeted for degradation (37, 52). The retrotranslocated UL37 proteins would then be targeted from the cytosolic compartment to mitochondria. However, UL37 proteins have not been detected in the cytosolic compartments of cells (29) (Williamson and Colberg-Poley, unpublished). Furthermore, a pUL37x1 mutant lacking the UL37x1 hydrophobic leader but retaining the juxtaposed basic residues localized to the cytosol and was not mitochondrially imported (29). These finding suggest that UL37 proteins are continuously membrane associated during their trafficking in the cell.
UL37 may be transported by vesicles or by direct contact between the ER and mitochondria through the mitochondrion-associated membrane compartment (15, 51). Contact points between mitochondria and the ER can comprise 5 to 20% of the total mitochondrial network (40). Bridges between mitochondria and the ER serve as conduits to transfer lipids from a subspecialized region of the ER (51). In addition, the hepatitis C core protein has recently been found to colocalize with mitochondrion-associated membrane markers in its trafficking from the ER to mitochondria, where it is peripherally associated to the outer mitochondrial membrane (42).
Recently, Thomas and colleagues (43) proposed a role for the multifunctional sorting protein PACS-2 in regulating ER-mitochondrion communication. As a sorting protein, PACS-2 interacts with ER membrane proteins and manipulates their subcellular trafficking. Moreover, PACS-2 is intimately associated with maintaining ER-mitochondrion contact and homeostasis. Strikingly, PACS-2 depletion (43) displays a phenotype remarkably analogous to that of pUL37x1 expression (5, 33) (Williamson and Colberg-Poley, unpublished). This common phenotype is marked by a transition of association from the ER to mitochondria, resulting in mitochondrial fragmentation, where ensuing punctate mitochondria maintain their membrane potential; induction of the unfolded protein response in the ER; efflux of ER calcium into the cytosol; and importantly, inhibition of apoptosis downstream of caspase-8 activation through blocking of cytochrome c release from the mitochondria. As UL37 isoforms all share cytosolic UL37x1 sequences, it is possible that they interact with PACS-2 or, alternatively, with a chaperone in trafficking to mitochondria.
|
ACKNOWLEDGMENTS |
|---|
|
FOOTNOTES |
|---|
M.S.M. and C.D.W. contributed equally to this work.
Present address: Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461.
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
